Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
(2025, April 28)
Contact Pure Med Spa Chicago today and ask how GLP-1s can transform your approach to stress, weight, and overall well-being.
Resmetirom (Rezdiffra TM ), a liver-directed thyroid hormone receptor- (THR-) agonist, received accelerated FDA approval in March 2024 as the first agent specifically indicated for non-cirrhotic MASH with moderate-to-advanced fibrosis (F2-F3), based on the MAESTRO-NASH trial demonstrating MASH resolution and fibrosis improvement
Sikiric P, Rucman R, Turkovic B, et al
US$ 28.60
US$ 26.62
US$ 29.36
